Literature DB >> 16148262

Evaluation of adverse effects in intracarotid propofol injection for Wada test.

N Mikuni1, M Takayama, T Satow, S Yamada, N Hayashi, N Nishida, J Taki, R Enatsu, A Ikeda, S Miyamoto, N Hashimoto.   

Abstract

The authors evaluated adverse effects of intracarotid propofol injection during a Wada test and their risk factors in 58 patients. Nineteen patients had an adverse effect, mostly in patients receiving more than 10 mg. For patients older than age 55 years or those requiring an injection dose greater than 20 mg to produce hemiplegia, propofol should be injected slowly and patients monitored for excitatory movements.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148262     DOI: 10.1212/01.wnl.0000176988.87336.ff

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Feasibility of the superselective test with propofol for determining eloquent brain regions in the endovascular treatment of arteriovenous malformations.

Authors:  José A Jordán González; Juan Carlos Llibre Guerra; José A Prince López; Frank Vázquez Luna; Raúl Marino Rodríguez Ramos; José Carlos Ugarte Suárez
Journal:  Interv Neuroradiol       Date:  2013-09-26       Impact factor: 1.610

2.  Provocative test with propofol: experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures.

Authors:  C E Feliciano; R de León-Berra; M S Hernández-Gaitán; H M Torres; O Creagh; R Rodríguez-Mercado
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-05       Impact factor: 3.825

3.  Mechanical thrombectomy in a pediatric patient with sedation aided by contralateral intra-arterial propofol injection: feasibility in an extreme condition.

Authors:  Davide Simonato; Mario Ganau; Paolo Feltracco; Francesco Causin; Marina Munari; Andrea Bortolato
Journal:  Childs Nerv Syst       Date:  2020-08-27       Impact factor: 1.475

4.  Tolerability of propofol in Wada testing.

Authors:  Faisal A Alsallom; Shobhit Sinha; Fahmi M Alsenani; Fawziah A Bamogaddam; Saeed H Wahass; Aurora B Canillo; Khurram A Siddiqui
Journal:  Neurosciences (Riyadh)       Date:  2014-07       Impact factor: 0.906

5.  Experience of adverse events with cerebral propofol testing in patients with drug resistant epilepsy.

Authors:  Marta Szantroch; Aleksandra Bala; Andrzej Rysz; Jarosław Żyłkowski; Andrzej Marchel
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

6.  Noninvasive Prediction of Language Lateralization Through Arcuate Fasciculus Tractography in Patients With Low-Grade Gliomas: Correlation With The Wada Test.

Authors:  Dongdong Wu; Meng Zhang; Jiefeng Geng; Xiaolei Chen
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

7.  Determination of language areas in patients with epilepsy using the super-selective Wada test.

Authors:  Kazuo Kakinuma; Shin-Ichiro Osawa; Hiroaki Hosokawa; Marie Oyafuso; Shoko Ota; Erena Kobayashi; Nobuko Kawakami; Kazushi Ukishiro; Kazutaka Jin; Makoto Ishida; Takafumi Sato; Mika Sakamoto; Kuniyasu Niizuma; Teiji Tominaga; Nobukazu Nakasato; Kyoko Suzuki
Journal:  IBRO Neurosci Rep       Date:  2022-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.